Nizatidine (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Nizatidine drug offered from Actavis Pharma, Inc.. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Nizatidine |
SUBSTANCE NAME: | NIZATIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2002-07-09 |
END MARKETING DATE: | 0000-00-00 |
Nizatidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Nizatidine from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2002-07-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-3137_1a6b71c7-fb20-42d2-86c7-4bb05965b014 |
PRODUCT NDC: | 0591-3137 |
APPLICATION NUMBER: | ANDA075616 |
Other NIZATIDINE Pharmaceutical Manufacturers / Labelers: